Garden Biotech(300401)On March 31, the number of shareholder accounts was 26.9k, an increase of 2.03% compared to the previous period.

Securities Star News: Recently, Huayuan Biotech disclosed that as of March 31, 2026, the number of shareholders of the company was 26.9k, an increase of 536.0 from March 20, representing a growth rate of 2.03%. The average number of shares held per household decreased from 20.6k shares in the previous period to 20.2k shares, and the average market value of shares held per household was 282.2k yuan.

Among individual stocks in the chemical pharmaceutical industry, Huayuan Biotech’s number of shareholders is below the industry average. As of March 31, the average number of shareholders in the chemical pharmaceutical industry was 34.7k. Regarding average shareholding market value, for A-share listed companies in the chemical pharmaceutical industry, the average market value of shares held per household was 400.4k yuan, while Huayuan Biotech was below the industry average.

Looking at the stock price, from March 20, 2026 to March 31, 2026, Huayuan Biotech’s price range decline was 1.27%. During this period, the number of shareholders increased by 536.0, a growth rate of 2.03%.

According to statistics, from March 20, 2026 to March 31, 2026, Huayuan Biotech saw net outflows of 101 million yuan from main force capital, net inflows of 90.9872 million yuan from speculative capital, and net inflows of 10.2456 million yuan from retail investors.

The above content is compiled by Securities Star from publicly available information and generated by an AI algorithm (Network Information Security Record No. 310104345710301240019). It does not constitute investment advice.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin